Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $14.6400 (2.38%) ($14.3000 - $14.8600) on Thu. Dec. 8, 2005. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.97% (three month average) | RSI | 70 | Latest Price | $14.6400(2.38%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -0.3% a day on average for past five trading days. | Weekly Trend | BCRX advances 9.6% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) EEM(6%) IWM(6%) QQQ(6%) SPY(6%) VWO(6%) | Factors Impacting BCRX price | BCRX will decline at least -3.485% in a week (0% probabilities). SHY(-3%) REMX(-2%) TLT(-1%) TIP(-1%) LQD(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.485% (StdDev 6.97%) | Hourly BBV | 0 () | Intraday Trend | 1.2% | | | |
|
5 Day Moving Average | $14.53(0.76%) | 10 Day Moving Average | $14.01(4.5%) | 20 Day Moving Average | $12.91(13.4%) | To recent high | -17.1% | To recent low | 72.8% | Market Cap | $2.583b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |